Back to Search Start Over

Low rate of nonrelapse mortality in under 4-year-olds with ALL given chemo-conditioning for HSCT: Phase III FORUM study

Authors :
Bader, Peter
Pötschger, Ulrike
Dalle, Jean-Hugues
Moser, Laura M.
Balduzzi, Adriana
Ansari, Marc
Buechner, Jochen
Güngör, Tayfun
Ifversen, Marianne
Krivan, Gergely
Pichler, Herbert
Renard, Marleen
Staciuk, Raquel
Sedlacek, Petr
Stein, Jerry
Heusel, Jan Robert
Truong, Tony
Wachowiak, Jacek
Yesilipek, Akif
Locatelli, Franco
Peters, Christina
Source :
Blood Advances; 20230101, Issue: Preprints
Publication Year :
2023

Abstract

1.In the Phase III FORUM trial, children younger than 4 years old with high-risk ALL had allogeneic HSCT after chemo-conditioning.2.Chemo-conditioning allowed HSCT with a low complication and mortality rate in this vulnerable patient cohort.

Details

Language :
English
ISSN :
24739529 and 24739537
Issue :
Preprints
Database :
Supplemental Index
Journal :
Blood Advances
Publication Type :
Periodical
Accession number :
ejs64058117
Full Text :
https://doi.org/10.1182/bloodadvances.2023010591